A phase III randomized double blind placebo controlled multi center study of ASA404 in combination with docetaxel in second line treatment of patients with advanced or metastatic stage IIIb IV non small cell lung cancer NSCLC

Supported projects > Other Supported Projects · 2009

Authors: Tuncay GÖKSEL

2009-2010, Other Supported Projects, R & D Project, Completed

View details